sameAs
Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.Whole-genome sequencing identifies a novel ABCB7 gene mutation for X-linked congenital cerebellar ataxia in a large family of Mongolian ancestry.Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases.Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease.Current advances in cell electrophysiology: applications for the analysis of intercellular communications within the neurovascular unit.Genetic studies of Russian patients with amyotrophic lateral sclerosis.Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease.New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).TOR1A polymorphisms in a Russian cohort with primary focal/segmental dystonia.Alpha-theta border EEG abnormalities in preclinical Huntington's disease.Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.Quantitative EEG during normal aging: association with the Alzheimer's disease genetic risk variant in PICALM gene.[Levodopa-carbidopa intestinal gel in the treatment of patients with Parkinson disease: results of a 12-month open study].Refined genetic location of the chromosome 2p-linked progressive muscular dystrophy gene.Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy.[Functional properties of dopaminergic neurons obtained from fibroblasts of a patient with PARK2 form of Parkinson's disease].Investigation of the effects of GABA receptor agonists in the differentiation of human induced pluripotent stem cells into dopaminergic neurons.X-linked nonprogressive congenital cerebellar hypoplasia: clinical description and mapping to chromosome Xq.A 30-year history of MPAN case from Russia.[Identification of people at the latent stage of Parkinson's disease (the PARKINLAR study): first results and an optimization of the algorithm].Expression analysis of suppression of tumorigenicity 13 gene in patients with Parkinson's disease.Research Center of Neurology — the 70-anniversarySpinocerebellar ataxia type 1 in RussiaC9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia populationmiRNA expression is highly sensitive to a drug therapy in Parkinson's disease.Studies of the candidate genes in X-linked congenital cerebellar hypoplasiaLack of alpha-synuclein gene mutations in families with autosomal dominant Parkinson's disease in RussiaMutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonismThe GTP cyclohydrolase I gene in Russian families with dopa-responsive dystoniaAssociation study of sporadic Parkinson's disease genetic risk factors in patients from Russia by APEX technologyA common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in RussiaPharmacokinetics and pharmacodynamics of gastroretentive delivery of levodopa/carbidopa in patients with Parkinson diseaseAnalysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's diseaseParkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
P50
Q33275606-0FA4F094-87B1-4763-A6DC-FE7B8006C956Q36800354-AF1AA801-CC1D-4FB4-9FBB-923753736419Q37058007-636D3C81-6E1B-4FF0-8343-CFEF4881CBCAQ38222379-3CC28929-123C-4549-925F-3AD7A30FCE72Q38909797-C281E3EB-F95C-4725-8E9C-F39A5A2CAE29Q39230378-E33B8136-D22B-45EB-AD01-7AB80D9E91F9Q39746877-2580CF49-C0A8-469C-B34F-F859358B92EFQ40237777-A6D131A5-B7C4-4F60-B907-ADC1D9EFF9CCQ41138244-A045D6DF-6C50-4B5C-9ACF-3FF3A303B15DQ41165703-52263952-0056-46EE-9DF4-110E6616D3BEQ41385214-35F31177-C261-4A98-B4DE-3C68AAB9A15EQ41522838-5813B3DB-879B-48E4-8F7A-BD4FCA4C1FADQ43485216-60C90959-D000-43B2-A736-068E746F29BDQ45300174-15ED4E4A-C734-443E-83AF-C40C63C3F152Q46471084-9408E7E4-696B-4EAA-9670-08EC75740A18Q48363683-C5C5CEDC-F92B-4CFB-B569-465819CF7389Q48617413-A9DBF5AA-C612-404F-BC4C-1F0869D7BD31Q48695612-7BBD9A64-1691-4E75-8FC5-DAE910BDE4FFQ48840222-06CB156C-223E-48E2-AAE8-95875BE1AA54Q50610782-989E0C44-65F6-4957-9E46-91EBF6D13DCDQ51339395-4CA7B27E-7507-4665-9417-C0E9E4EEE0D8Q52200962-D8ADE06F-6556-4AFF-BEE8-AE693F4ACD0CQ52597689-4AC6C9AE-94E1-43A0-A2C9-DF80592E9657Q53541997-A2E858C5-E935-46FA-A338-A32DB7298A41Q54439314-79163527-381D-4831-9A96-8086525ECA52Q57902525-4E5C2A80-15A7-47B7-9546-E8ADFC81EC0AQ58027536-8B0270C5-D4BF-4180-90CF-7F5D3AE71DD0Q58199011-A60B8973-6E14-4A28-9876-48592FDA0B2EQ64857207-DE7235C7-9B85-4760-B012-6F4B7EAEDC47Q73398542-20781C20-DE0A-4A29-8631-C49F792E31B1Q73493937-FCC230E7-5C57-4D1A-98B6-8A939F3C1D96Q73730259-10B7FA9C-6654-494F-8A41-18D0BB0FFDB4Q74648208-9C388835-5991-4AEC-B514-346655508901Q80021122-132BD7D7-2764-49C6-97CC-CF2EC63D355EQ80048963-08237E8D-4FF4-439A-9B44-F89DB23C9091Q83540369-3F7A49C3-145C-400A-AC8A-1D91E88AA85FQ84941328-D4DFC05A-3E09-43CE-9473-34CF8137B192Q95929654-CC1D753E-FF2C-4669-A7C8-C1902FB68E2E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2704-6282
@en
name
Sergei Nikolajewitsch Illarioschkin
@de
Sergey Illarioshkin
@en
Sergey N Illarioshkin
@ast
Sergey N Illarioshkin
@es
Sergey N Illarioshkin
@nl
Иллариошкин, Сергей Николаевич
@ru
type
label
Sergei Nikolajewitsch Illarioschkin
@de
Sergey Illarioshkin
@en
Sergey N Illarioshkin
@ast
Sergey N Illarioshkin
@es
Sergey N Illarioshkin
@nl
Иллариошкин, Сергей Николаевич
@ru
altLabel
Sergei Illarioschkin
@de
Sergey N Illarioshkin
@en
Sergey Nikolayevich Illarioshkin
@en
prefLabel
Sergei Nikolajewitsch Illarioschkin
@de
Sergey Illarioshkin
@en
Sergey N Illarioshkin
@ast
Sergey N Illarioshkin
@es
Sergey N Illarioshkin
@nl
Иллариошкин, Сергей Николаевич
@ru
P106
P1153
7004025426
P21
P31
P4012
P496
0000-0002-2704-6282
P569
1963-07-04T00:00:00Z